Hong Du
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA modifications and cancer 3
- Cancer therapeutics and mechanisms 2
- Glycosylation and Glycoproteins Research 2
- Oncology 5
- Cancer Treatment and Pharmacology 2
- Co-authors
- Ershuai Zhang (2 shared papers)Boyi Song (2 shared papers)Yuanjie Shi (2 shared papers)Xiangfei Han (2 shared papers)Zhiqiang Cao (1 shared paper)Yang Lü (1 shared paper)Chengbiao Yang (1 shared paper)Hui Zhu (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Molecules (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Materials Chemistry B (1 paper)Molecular Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hong Du
19 papers receiving 576 citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Pharmaceutical Science 149
- Biomaterials 82
- Cancer Research 87
- Molecular Biology 265
- Surfaces, Coatings and Films 24
Countries citing papers authored by Hong Du
This map shows the geographic impact of Hong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Du more than expected).
Fields of papers citing papers by Hong Du
This network shows the impact of papers produced by Hong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Du. The network helps show where Hong Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Hong Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions Hit paper breakdown → | 2020 | 245 |
| 2 | 2009 | 85 | |
| 3 | 2020 | 66 | |
| 4 | 2019 | 33 | |
| 5 | 2023 | 18 | |
| 6 | 2021 | 17 | |
| 7 | 2011 | 16 | |
| 8 | 2011 | 16 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 14 | |
| 11 | 2011 | 12 | |
| 12 | 2011 | 10 | |
| 13 | 2023 | 9 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2025 | 0 |
About Hong Du
Hong Du is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pharmacology, having authored 21 papers that have together received 578 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Prostate Cancer Treatment and Research (3 papers), RNA modifications and cancer (3 papers), MicroRNA in disease regulation (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Fluoride Effects and Removal (2 papers). The work is most often cited by research in Pharmaceutical Science (149 citations), Biomaterials (82 citations), Cancer Research (87 citations), Molecular Biology (265 citations) and Surfaces, Coatings and Films (24 citations). Hong Du has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ershuai Zhang, Boyi Song, Yuanjie Shi, Xiangfei Han, Zhiqiang Cao, Yang Lü, Chengbiao Yang, Hui Zhu, Ke Wang and Jinbing Xie. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecules, Molecular Cancer Therapeutics, Journal of Materials Chemistry B and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.